J Cancer 2021; 12(19):5929-5937. doi:10.7150/jca.57951 This issue Cite

Review

Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases

Hongjiao Xiang, Zecheng Wu, Junmin Wang, Tao Wu

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Citation:
Xiang H, Wu Z, Wang J, Wu T. Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. J Cancer 2021; 12(19):5929-5937. doi:10.7150/jca.57951. https://www.jcancer.org/v12p5929.htm
Other styles

File import instruction

Abstract

Graphic abstract

The human patatin-like phospholipase domain-containing 3 gene (PNPLA3) is highly expressed in liver and adipose tissue and encodes a transmembrane polypeptide chain containing 481 amino acids. The I148M variant of PNPLA3 is a single nucleotide polymorphism, which is related to a variety of liver and cardiovascular diseases and their complications (such as non-alcoholic fatty liver disease, liver fibrosis, coronary artery disease). This review mainly describes the pathophysiological effects of PNPLA3 and its variants, and their roles in the progression of liver disease and its complications.

Keywords: PNPLA3, NAFLD, type 2 diabetes, liver fibrosis, hepatocellular carcinoma


Citation styles

APA
Xiang, H., Wu, Z., Wang, J., Wu, T. (2021). Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. Journal of Cancer, 12(19), 5929-5937. https://doi.org/10.7150/jca.57951.

ACS
Xiang, H.; Wu, Z.; Wang, J.; Wu, T. Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. J. Cancer 2021, 12 (19), 5929-5937. DOI: 10.7150/jca.57951.

NLM
Xiang H, Wu Z, Wang J, Wu T. Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. J Cancer 2021; 12(19):5929-5937. doi:10.7150/jca.57951. https://www.jcancer.org/v12p5929.htm

CSE
Xiang H, Wu Z, Wang J, Wu T. 2021. Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. J Cancer. 12(19):5929-5937.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image